Clinical Study
Evaluation of Mediators Associated with the Inflammatory Response in Prostate Cancer Patients Undergoing Radiotherapy
Table 2
Detailed descriptive results on plasma levels of the selected inflammatory molecules for all measurement points.
| pg/ml or ng/ml^ | Mean | SD | Median | Minimum | Maximum | 75th perc | 25th perc |
| CCL2 baseline | 131.5 | 32.1 | 127.4 | 66.7 | 203.3 | 110.0 | 139.8 | CCL2 8 Gy | 136.8 | 37.7 | 134.6 | 60.5 | 200.4 | 111.9 | 171.4 | CCL2 50 Gy | 146.6 | 41.8 | 145.8 | 57.7 | 217.1 | 118.6 | 167.1 | CCL2 end RT | 157.3 | 34.5 | 158.4 | 102.6 | 240.8 | 131.2 | 174.1 | CCL2 1 mos | 167.9 | 79.7 | 143.2 | 74.6 | 461.7 | 127.5 | 187.2 |
| IL-1b baseline | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | IL-1b 8 Gy | 0.0 | 0.1 | 0.0 | 0.0 | 0.5 | 0.0 | 0.0 | IL-1b 50 Gy | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | IL-1b end RT | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | IL-1b 1 mos | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 |
| IL-6 baseline | 1.6 | 1.2 | 1.6 | 0.0 | 3.5 | 0.3 | 2.5 | IL-6 8 Gy | 1.4 | 1.3 | 2.1 | 0.0 | 3.2 | 0.2 | 2.3 | IL-6 50 Gy | 1.6 | 1.4 | 1.6 | 0.0 | 4.7 | 0.2 | 2.3 | IL-6 end RT | 1.6 | 1.1 | 1.8 | 0.0 | 3.2 | 1.3 | 2.3 | IL-6 1 mos | 1.7 | 1.2 | 2.2 | 0.0 | 3.9 | 0.5 | 2.5 |
| CXCL8 baseline | 5.7 | 2.0 | 5.2 | 3.7 | 10.4 | 4.3 | 5.9 | CXCL8 8 Gy | 5.5 | 2.4 | 4.6 | 3.4 | 12.5 | 3.9 | 6.4 | CXCL8 50 Gy | 5.7 | 2.0 | 5.1 | 3.7 | 11.4 | 4.4 | 6.2 | CXCL8 end RT | 6.3 | 2.7 | 5.4 | 2.9 | 13.4 | 4.6 | 7.7 | CXCL8 1 mos | 8.3 | 9.1 | 5.7 | 4.1 | 46.1 | 4.7 | 7.2 |
| PTX3 baseline | 3.3 | 1.1 | 3.0 | 1.8 | 5.6 | 2.3 | 4.3 | PTX3 8 Gy | 3.9 | 1.2 | 3.9 | 1.9 | 6.3 | 3.1 | 4.6 | PTX3 50 Gy | 3.3 | 1.1 | 3.3 | 1.6 | 5.6 | 2.5 | 4.0 | PTX3 end RT | 3.5 | 1.3 | 3.7 | 1.4 | 6.3 | 2.6 | 4.1 | PTX3 1 mos | 3.1 | 1.1 | 3.1 | 1.1 | 5.1 | 2.0 | 4.0 |
| TNF alpha baseline | 3.1 | 2.5 | 3.9 | 0.0 | 7.4 | 0.4 | 4.9 | TNF alpha 8 Gy | 2.7 | 2.3 | 2.9 | 0.0 | 6.5 | 0.4 | 4.9 | TNF alpha 50 Gy | 2.8 | 2.6 | 2.7 | 0.0 | 9.2 | 0.2 | 4.6 | TNF alpha end RT | 2.7 | 2.2 | 2.8 | 0.0 | 6.1 | 0.2 | 4.5 | TNF alpha 1 mos | 3.1 | 2.2 | 3.6 | 0.0 | 7.0 | 1.2 | 4.3 |
|
|
^pg/ml for IL-1b, IL-6, CXCL8, CCL2, and TNF alpha; ng/ml: PTX3; SD: standard deviation; perc: percentile; 1 mos: 1 month; RT: radiotherapy.
|